drugset / Trial / NCT04393441
Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to compare the efficacy and safety of a new artificial tear formulation (011516X) with Systane® Ultra Multidose for 90 days in participants with Dry Eye Disease (DED).
Timeline
- Start
- 2020-06-29
- Primary completion
- 2021-06-15
- Completion
- 2021-06-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 011516X | Unknown | — | Topical |
| Comparator | Systane Ultra Multidose | Unknown | — | Topical |
| Background | Carboxymethylcellulose | Other / unclassified | — | Topical |